Trump Strikes Deal With German Merck on Tariffs, IVF Costs

President Donald Trump has reached a deal with the German pharmaceutical company Merck KGaA. The agreement involves reducing the prices of Merck's fertility medicines in the United States, in exchange for relief from threatened tariffs. The deal is a step towards fulfilling Trump's campaign promise of making in-vitro fertilization (IVF) more affordable and accessible for Americans. Fertility treatments can be prohibitively expensive, and this agreement aims to address that issue. The details of the price reductions and the specific tariff relief measures have not been disclosed. However, the announcement highlights the Trump administration's efforts to address the high costs of healthcare, particularly for specialized medical procedures like IVF. The agreement with Merck KGaA is a significant development in the ongoing efforts to make fertility treatments more accessible and financially viable for American patients.